Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
Mayo Clinic Proceedings|May 20, 2025
Association Between Body Mass Index and Age at End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease in the United States and JapanTatsuya Suwabe, Vicente E Torres, Lisa E Vaughan, et al.Journal of Palliative Medicine|November 28, 2017
A Soup Service for Advanced Digestive Cancer Patients with Severe Anorexia in Palliative CareHideaki Kawabata, Naoki Kakihara, Yoko Nishitani, et al.Advances in Therapy|November 29, 2024
Baseline Characteristics of the DISCOVER CKD Prospective CohortCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.American Journal of Nephrology|August 22, 2024
The Lived Experience of Patients with Chronic Kidney Disease: Insights From DISCOVER CKDCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.Advances in Therapy|July 3, 2024
Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective CohortHiddo Heerspink, Stephen Nolan, Juan-Jesus Carrero, et al.Scientific Reports|November 10, 2024
Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex)Sho Shimamoto, Takako Nakahara, Shunsuke Yamada, et al.Kidney International Reports|September 12, 2022
Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of UtilityGlen James, Juan Jose Garcia Sanchez, Juan Jesus Carrero, et al.Eclinicalmedicine|July 16, 2024
Projecting the clinical burden of chronic kidney disease at the patient level (<i>Inside CKD</i>): a microsimulation modelling studyGlenn M Chertow, Ricardo Correa-Rotter, Kai-Uwe Eckardt, et al.Clinical and Experimental Nephrology|July 6, 2024
Guidelines for clinical evaluation of chronic kidney disease in early stages : AMED research on regulatory science of pharmaceuticals and medical devicesYuka Sugawara, Eiichiro Kanda, Takayuki Hamano, et al.Cancer Treatment and Research Communications|July 4, 2024
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancerKanako Sakaeda, Koji Kurose, Yuki Matsumura, et al.Pageof 15